How to get NAD+ has three real answers, and they separate on friction rather than on price. One asks for an afternoon and a booking, one asks for a prescriber, and one asks for nothing except your own judgement about a listing.
Key takeaways
- The clinic route costs the most time: a booking, a session measured in hours, and pricing usually structured as a package rather than a single visit.
- The prescription route exists for NAD+ where it does not exist for the peptides on this site, because NAD sits in FDA's 503A Category 1, under evaluation, with a stated non-enforcement position rather than an approval.
- The research-supplier route has the least friction and the least supervision. Material is sold for laboratory use, and no seller is permitted to discuss dosing or reconstitution with you.
- One question survives all three routes: is the material pharmaceutical grade, and does the batch report include bacterial endotoxins. FDA tied reports of severe chills, shaking, vomiting and fatigue after NAD+ injectables to excessive endotoxin levels.
- Low friction is not the same as low risk. The route that asks least of your week is the route that leaves the most verification to you.
The vendor we point lifters to
NAD+ from Ascension Peptides
Independently assayed material, dispatched from the US. The vial drops by half with the code below.
Quoted per 100 mg because NAD+ is dosed in hundreds of milligrams, not the single milligrams a peptide vial holds. Buying 3, 5 or 10 takes 3%, 5% or 10% off the list price. Free shipping starts at $250.
- Two independent lab reports per batch
- Free delivery above $250
- Same-day dispatch on orders before 2pm CST
Research material, laboratory use only, not for human consumption. Affiliate links: we may earn a commission at no extra cost to you. Pricing verified August 20, 2026.
How to get NAD+: the three routes, ranked by friction
Friction here means what the route takes out of your week before anything reaches you, and what it hands back.
| Route | What it asks of you | What it gives you | What stays unverified |
|---|---|---|---|
| Clinic or drip bar | A booking, travel, and a session measured in hours, usually sold as a course rather than a one-off | Supervision, a clinician in the room, no logistics | The grade of the bulk substance behind the bag |
| Prescriber plus compounding pharmacy | A consultation, a prescription, and a pharmacy that will take it | A preparation made for you by name, and a professional in the loop | That compounded is not approved, and the ingredient policy is provisional |
| Research supplier | Nothing but your own reading of a listing and a certificate | Documentation you can inspect before paying, and material in days | Everything a clinician would otherwise carry, including whether this is a good idea |
Read the last column before the first. The routes trade supervision against control, and the one that asks least of your week gives you the largest share of the responsibility.
The clinic route: the most time, the least visibility
An infusion appointment is the highest-friction option by a distance. You book, you travel, you sit for a substantial part of an afternoon, and clinics generally price a course of sessions rather than a single one, which turns the decision into a commitment before you know how you respond.
What you gain is real: a clinician present, an environment set up for it, and someone to react if a reaction starts. What you do not gain is any view of the material. The cost of the substance is invisible inside a service price, and no part of the appointment tells you what grade of bulk the compounder used.
That gap is the one FDA wrote about. Its notice reminding compounders to use ingredients suitable for sterile compounding, content current as of 10/30/2024, says the agency "is aware of compounders using food-grade nicotinamide adenine dinucleotide (NAD+) sold by repackagers to make intravenous products," and that food-grade ingredients "are not suitable for compounding sterile drugs without appropriate processing, due to the high risk of contamination with microbes and endotoxins."
So the useful thing to do with a clinic appointment is to spend two minutes of it asking questions. Who compounds this. Is the substance pharmaceutical grade. Does the certificate include endotoxin testing. Searching for a provider is covered in NAD+ near me, and what a session costs against a vial in NAD+ price.
The prescription route: unusual, and worth understanding
On this site, "get a prescription" is normally a dead end. There is no approved product behind BPC-157, MOTS-c or retatrutide, no listed bulk substance, and nothing a pharmacy can lawfully compound, which is why how to get MOTS-c ends where it does.
NAD+ breaks that pattern. NAD appears in FDA's 503A Category 1, "Bulk Drug Substances Under Evaluation," on the category lists updated May 14, 2026. Category 1 means FDA does not intend to take action against a compounder for compounding with the substance provided its guidance conditions are met. Say the rest of it out loud too: that is non-enforcement during an evaluation that has not finished, not an approval, and the categories get revised.
Practically, the route runs consultation, prescription, pharmacy. A telehealth service may run all three inside one funnel. The friction is moderate: a booked call, a fee, a wait for compounding and shipping. What you get is a preparation made for a named patient and a prescriber who is accountable. What you do not get is an approved medicine, and FDA's compounding questions and answers is explicit that compounded drugs are not FDA approved. The precise legal picture is in NAD+ without prescription.
The research-supplier route: fastest, and entirely on you
This is the low-friction option: read a listing, read the certificate, pay, and the material moves. Domestic sellers dispatch quickly, and the presentation is a gram rather than the few milligrams a peptide vial holds.
What the route asks instead is judgement, and it asks for it in advance. Before paying, the things worth confirming are a batch-specific certificate rather than a catalog one, a named third-party laboratory, identity by mass spectrometry alongside purity by chromatography, a bacterial endotoxins result, domestic dispatch, and research-use language with no human-use claims anywhere on the page. That list is expanded in NAD+ where to buy, and the ranking logic behind it in best NAD+ source.
The listing we track sits in this route. Ascension's NAD+ 1,000 mg lists at $104.00 and falls to $52.00 with the code, which is $5.20 per 100 mg, and publishes two independent third-party reports per batch, currently Kovera Labs 25-05260628 and MZ Biolabs 25-01260229, with same-day dispatch before 2pm CST. That is what the page states, read on the date above, not a laboratory check we ran ourselves.
One thing this route cannot do is answer a dosing question. Research sellers are not permitted to discuss reconstitution or amounts, and they will say so if you ask. PeptideDosage covers that side separately with a NAD+ dosage reference and a NAD+ calculator.
How to get NAD+ IV specifically, and why the bar is higher
Searches for how to get NAD+ IV are asking about the intravenous format, and the format is what raises the stakes rather than the substance. Anything infused bypasses every barrier the body would otherwise put in the way, which is exactly why FDA's notice records adverse event reports "following use of NAD+ injectable drugs, including severe chills, shaking, vomiting and fatigue with some requiring medical treatment," reactions the agency described as "consistent with excessive levels of endotoxins."
There is no consumer route to a sterile intravenous NAD+ product that skips both a clinic and a pharmacy, and no research listing is offering one. Material sold for laboratory use is not a finished sterile drug, and the format question is handled in buy NAD+ injection.
What is genuinely unavailable without a clinician
It is worth being exact about the boundary, because marketing pages blur it in both directions.
Without a clinician you cannot obtain a finished sterile intravenous product, you cannot obtain anything carrying an approved label, and you cannot obtain supervision. Those three are the actual content of the clinical routes, and no research listing substitutes for them.
What you can obtain without a clinician is laboratory research material, sold with research-use language, no dosing guidance and no clinical relationship attached. That is a genuine option rather than a loophole, and it is also the whole of what it is: nobody in that transaction is assessing whether this is a sensible thing for you to do.
The tell for a marketing funnel dressed as a clinical route is the sequence. A real prescriber route starts with an assessment and can end in a no. A funnel starts with a product page, collects payment, and treats the consultation as a formality on the way to fulfilment. If the consultation cannot plausibly result in being turned down, it is not gatekeeping anything.
Where readers realistically land
Most people reading this arrive from a flat training month, not from a clinical question, so the honest ending is a narrow one. There is no finished human efficacy trial showing exogenous NAD+ improves training capacity, and the registered trial list is the check on anyone who says otherwise. What is well established is the biochemistry, and biochemistry is not an outcome.
Before spending on any of the three routes, the cheaper explanations deserve their turn: sleep debt, an aggressive deficit, volume without a deload, or lean-mass loss on an incretin drug, which we cover in sleep and myostatin, resistance training and myostatin and myostatin inhibitors and GLP-1 muscle loss.
If you have worked through those and still want to run it, the realistic landing point is the research route with the verification done properly, or a clinic where you are willing to ask the grade question and walk out if it cannot be answered.
Frequently asked questions
What is the fastest way to get NAD+?
A domestic research supplier, which can dispatch the same day and needs nothing from you except payment and your own reading of the listing. That speed is exactly why the verification has to happen before checkout rather than after delivery.
Can I get NAD+ on prescription?
A prescriber can write for a compounded preparation, and a 503A pharmacy can make it, because NAD is in FDA's Category 1 list of bulk substances under evaluation. That is a non-enforcement position while the evaluation runs, and compounded preparations remain unapproved products.
How long does a NAD+ IV appointment take?
Clinics describe infusions running for a substantial part of an afternoon rather than minutes, and typically sell them as a course of sessions. Confirm the schedule and the total commitment with the provider before booking, since the structure varies between clinics.
What should I ask a clinic before an infusion?
Who compounds the preparation, whether the substance is pharmaceutical grade rather than food grade, and whether the certificate of analysis includes a bacterial endotoxins result. FDA's compounding notice makes all three questions concrete rather than pedantic.
Will a research supplier tell me how much to use?
No. Research chemical sellers are not permitted to discuss dosing or reconstitution and will decline the question. Dosing references live outside the sales channel, and nothing about a supplier's willingness to answer should be read as clinical guidance.
This article is for educational purposes only and is not medical advice. NAD+ is a coenzyme rather than an approved injectable medicine: there is no FDA-approved NAD+ drug product, material sold by research suppliers is labeled for laboratory use only and not for human consumption, and compounded preparations exist under a stated enforcement policy rather than an approval. Speak with a qualified healthcare professional before making any decision involving injections, infusions or off-label compounds.